Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Market Cap	15.17B -43.2%
Revenue (ttm)	14.90B +2.3%
Net Income	1.79B -22.0%
EPS	0.39 -22.2%
Shares Out	4.51B
PE Ratio	8.63
Forward PE	8.14
Dividend	0.18 (5.41%)
Ex-Dividend Date	Jun 2, 2026

Volume	63,174,725
Open	3.400
Previous Close	3.360
Day's Range	3.400 - 3.570
52-Week Range	3.260 - 7.390
Beta	0.34
Analysts	Strong Buy
Price Target	6.08 (+74.21%)
Earnings Date	Mar 27, 2026

About HKG:1066

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China and internationally. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments. The company offers medical device products, including safe infusion, clinical nursing, perioperative, endocrine, urinary, rehabilitation system, and extracorporeal circulation solutio...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1988
• Employees: 13,307
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1066

Financial Performance

In 2025, HKG:1066's revenue was 13.39 billion, an increase of 2.31% compared to the previous year's 13.09 billion. Earnings were 1.61 billion, a decrease of -21.99%.

Financial numbers in CNY